Clinical Trial

Early Transcatheter Mitral Valve Repair After Myocardial Infarction

Study acronym: EMCAMI
Recruiting
View on ClinicalTrials.gov →
Summary
To explore the impact of early transcatheter edge-to-edge repair of acute functional mitral regurgitation after myocardial infarction on the combined incidence of death and heart-failure associated hospitalisations at one-year follow-up, and quality of life and LV remodelling at two-year follow-up.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-27; most recent amendment 2025-10-15.
Status change: Not Yet Recruiting → Recruiting 2025-10-15
Trial Details
NCT Number NCT06282042
Lead Sponsor Fundación para la Investigación Biosanitaria del Principado de Asturias
Collaborators: Meditrial Europe Ltd.
Conditions Acute Mitral Regurgitation
Enrollment 250 participants
Start Date 2024-12-24
Primary Completion 2027-06-16 (estimated)
Study Completion 2028-06-16 (estimated)
Updated on ClinicalTrials.gov 2025-10-20